In 2020, Beijing Novel Medical Equipment Co., Ltd. started a new journey and was once again recognized as a "National High-Tech Enterprise" due to their strong R&D team, technical capabilities, and continuous innovation.
The "National High-Tech Enterprise" status is a special qualification set up by the country to support and encourage business development, adjust the industrial structure, and enhance national economic competitiveness. It holds a strategic position in China's economic development. For many years, high-tech enterprises have received significant attention from all levels of government, with various policy measures encouraging and supporting their rapid growth. The company's successful acquisition of this qualification through rigorous selection and evaluation signifies a solid step forward in research and development in the field of national strategic innovation, relying on scientific and technological innovation talents, the ability to transform scientific achievements, and independent intellectual property.
Since its establishment, Novel Medical has independently innovated and successfully developed three major products: intelligent nuclear radiation monitoring systems, multimodal animal PET/SPECT/CT integrated machines, and clinical SPECT systems. The company will continue to inherit Tsinghua University's excellent professional skills and pragmatic research spirit, attract high-quality talent, increase research and development investment, focus on independent innovation, and protect intellectual property. By further enhancing its technological innovation and achievement transformation capabilities, the company aims to provide strong technical support for sustainable, healthy, and rapid development, striving to become a leader in China's nuclear safety and nuclear medicine industry.
Language
